What does dulaglutide cost in each channel?
Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.
| Channel | Price (USD) | Notes |
|---|---|---|
| With insurance | $0 to $25per month | Typical copay when a commercial plan covers Trulicity and the manufacturer savings card is applied. Medicare Part D plans cover dulaglutide for type 2 diabetes with plan specific copays, and the savings card cannot be used with government insurance. [1] [4] |
| List price (Trulicity) | $1,007per month | Manufacturer list price (wholesale acquisition cost) for Trulicity is $1,006.93 per month, defined by the manufacturer as four single-dose pens, and is the same at every strength from 0.75 mg to 4.5 mg (list price as of January 1, 2026; checked 2026-09-27). Retail pharmacies may add a margin on cash purchases. [1] [2] |
| Self-pay through the manufacturer pharmacy | From $389per month | The manufacturer's direct-to-patient pharmacy sells Trulicity self-pay from $389 per month at each strength, 0.75 mg to 4.5 mg (checked 2026-09-27). A prescription is required, terms apply, and taxes or fees may be added. [5] |
| Compounded pharmacy | Not published | No compounded product. Dulaglutide is a component of a marketed approved drug, and it is not available as a bulk substance for compounding. FDA listed dulaglutide injection as in shortage in its October 2024 to February 2025 GLP-1 updates, with all presentations available; it is not listed in FDA's shortage database as of September 27, 2026. [3] [6] [7] |
What is the list price of dulaglutide?
The list price is Lilly's wholesale acquisition cost for a monthly supply, which the manufacturer defines as four pens ($1,006.93 as of January 1, 2026), and it does not vary by dose. No generic dulaglutide is marketed as of the verification date.
Does insurance cover dulaglutide?
Trulicity is approved for type 2 diabetes (including cardiovascular risk reduction) and is widely covered by commercial plans and Medicare Part D, often with step therapy or a preferred GLP-1 agonist on the formulary. It is not approved for weight management.
What changes the price?
- Formulary status of Trulicity versus other GLP-1 agonists on the plan
- Manufacturer savings card eligibility (commercial insurance only)
- Retail pharmacy margin on cash purchases
- Medicare Part D coverage phase and plan copay design
- Manufacturer self-pay pharmacy price versus list price
Frequently asked questions
How much does dulaglutide cost without insurance?
About $389 to $1,007 per month at the verification date, depending on the channel: list price (Trulicity), self-pay through the manufacturer pharmacy. See the table above for what each figure includes. [1] [2] [5]
Does insurance cover dulaglutide?
Trulicity is approved for type 2 diabetes (including cardiovascular risk reduction) and is widely covered by commercial plans and Medicare Part D, often with step therapy or a preferred GLP-1 agonist on the formulary. It is not approved for weight management. [1] [4]
What is the list price of dulaglutide?
The list price is Lilly's wholesale acquisition cost for a monthly supply, which the manufacturer defines as four pens ($1,006.93 as of January 1, 2026), and it does not vary by dose. No generic dulaglutide is marketed as of the verification date. [1] [2] [5]
Related pages
- Dulaglutide: evidence, legality, and access
- Dulaglutide vs exenatide (Exenatide cost)
- Dulaglutide vs mazdutide
- Dulaglutide vs retatrutide (Retatrutide cost)
- Liraglutide vs dulaglutide (Liraglutide cost)
- Semaglutide vs dulaglutide (Semaglutide cost)
- Tirzepatide vs dulaglutide (Tirzepatide cost)
- Type 2 diabetes: peptide evidence
- Cardiovascular risk reduction: peptide evidence
- Where it is legal to get: peptide law by state
- Full cost index
Sources
- [1]Manufacturer pricing page: dulaglutide list price and savings options, accessed 2026-09-27
- [2]FDA prescribing information for Trulicity (dulaglutide) injection, via DailyMedFDA
- [3]FDA: Compounding and the FDA, questions and answersFDA
- [4]Medicare.gov: prescription drug coverage (Part D and outpatient drugs)
- [5]Manufacturer direct pharmacy: Trulicity self-pay price, accessed 2026-09-27
- [6]FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (GLP-1 shortage status updates, including liraglutide, and the April 1, 2026 policy update on essentially copies)FDA, 2026
- [7]FDA Drug Shortages database (dulaglutide not listed as of September 27, 2026)FDA, 2026